Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization

Authors

Keywords

Journal

Volume 67, Issue 3, Pages 723-728

Publisher

Springer Nature

Online

2010-09-20

DOI

10.1007/s00280-010-1457-z

References

View 3 related references

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now